Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Etodolac Improves 5-FU Sensitivity of Head and Neck Cancer Cells through Inhibition of Thymidylate Synthase

SHOGO MURATA, MAKOTO ADACHI, MITOMU KIOI, SOICHIRO TORIGOE, KEI IJICHI, YASUHISA HASEGAWA, TETSUYA OGAWA, MIHIR K. BHAYANI, STEPHEN Y. LAI, KENJI MITSUDO and IWAI TOHNAI
Anticancer Research September 2011, 31 (9) 2893-2898;
SHOGO MURATA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAKOTO ADACHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MITOMU KIOI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Kioi{at}yokohama-cu.ac.jp
SOICHIRO TORIGOE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEI IJICHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHISA HASEGAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TETSUYA OGAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIHIR K. BHAYANI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHEN Y. LAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENJI MITSUDO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IWAI TOHNAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    A: Sensitivity of UM-SCC-23 and UM-SCC-23F/R cells treated with 5-FU. Dose-dependent effect of 5-FU on survival in both cell lines. Each data point is the mean of three independent experiments. Error bars show standard deviations. B: Sensitivity of UM-SCC 23 and UM-SCC 23 F/R cells treated with etodolac. Dose-dependent effect of etodolac on survival in both cell lines. Each data point is the mean of three independent experiments. Error bars show standard deviations. C: Sensitivity of UM-SCC-23 and UM-SCC-23F/R cells to treatment with 5-FU and etodolac (50 μg/ml). Dose-dependent effect of 5-FU and etodolac on survival in both cell lines. Each data point is the mean of three independent experiments. Error bars show standard deviations. **p<0.01, t-test.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    A: Cytotoxic activity of 5-FU and etodolac combinations against UM-SCC-23 cells. Data shown are mean of triplicate determinations, with error bars representing SD. Experiments were repeated at least two times with similar results. B: Isobologram analysis of the data shown in (A). The IC50 values of each drug are plotted; the solid line represents an additive effect, while the values of the combination below this line indicate synergism of the combination.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Western blot analysis of cyclooxygenase-2 (COX-2) and thymidylate synthase (TS) expression on treatment of UM-SCC-23 and UM-SCC-23F/R cells with etodolac.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    A: Sensitivity of UM-SCC-23 and UM-SCC-23F/R cells treated with 5-FU in the presence of IL-1β. Each data point is the mean of three independent experiments. Error bars show standard deviations. B: Sensitivities of UM-SCC-23 and UM-SCC-23F/R cells treated with 5-FU and etodolac in the presence of IL-1β. Each data point is the mean of three independent experiments. Error bars show standard deviations. *p<0.05, t-test.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Western blot analysis of cyclooxygenase-2 (COX-2) and thymidylate synthase (TS) expression on treatment with etodolac and interleukin-1β of UM-SCC-23 and UM-SCC-23F/R cells.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 31, Issue 9
September 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Etodolac Improves 5-FU Sensitivity of Head and Neck Cancer Cells through Inhibition of Thymidylate Synthase
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Etodolac Improves 5-FU Sensitivity of Head and Neck Cancer Cells through Inhibition of Thymidylate Synthase
SHOGO MURATA, MAKOTO ADACHI, MITOMU KIOI, SOICHIRO TORIGOE, KEI IJICHI, YASUHISA HASEGAWA, TETSUYA OGAWA, MIHIR K. BHAYANI, STEPHEN Y. LAI, KENJI MITSUDO, IWAI TOHNAI
Anticancer Research Sep 2011, 31 (9) 2893-2898;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Etodolac Improves 5-FU Sensitivity of Head and Neck Cancer Cells through Inhibition of Thymidylate Synthase
SHOGO MURATA, MAKOTO ADACHI, MITOMU KIOI, SOICHIRO TORIGOE, KEI IJICHI, YASUHISA HASEGAWA, TETSUYA OGAWA, MIHIR K. BHAYANI, STEPHEN Y. LAI, KENJI MITSUDO, IWAI TOHNAI
Anticancer Research Sep 2011, 31 (9) 2893-2898;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Cell-cycle Distribution and Thymidilate Synthatase (TS) Expression Correlate With 5-FU Resistance in Head and Neck Carcinoma Cells
  • Google Scholar

More in this TOC Section

  • Ginsenoside Rh4 Induces Apoptosis Through ROS-Mediated Fas Signaling in Human Nasopharyngeal Carcinoma NPC/HK1 Cells
  • Genome-wide Analysis Highlights rs4671908 and rs2238431 as Predictors of Survival in Nasopharyngeal Carcinoma
  • Implications of the Cuproptosis Protein SLC31A1 for the Immune Microenvironment and Temozolomide Sensitivity in Glioblastoma
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire